Integral Ad Science (NASDAQ:IAS – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, November 12th. Analysts expect Integral Ad Science to post earnings of $0.09 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Integral Ad Science Stock Performance
Shares of IAS stock opened at $11.85 on Tuesday. Integral Ad Science has a 1 year low of $7.98 and a 1 year high of $17.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.76 and a current ratio of 3.76. The stock has a fifty day moving average price of $11.02 and a 200 day moving average price of $10.33. The stock has a market cap of $1.91 billion, a PE ratio of 1,185.00, a P/E/G ratio of 1.41 and a beta of 1.52.
Analyst Upgrades and Downgrades
Several analysts have issued reports on IAS shares. Barclays upped their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Monday, August 5th. Raymond James boosted their target price on shares of Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a report on Friday, August 2nd. Morgan Stanley lifted their price objective on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 23rd. Finally, Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a report on Monday, August 5th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.40.
Insider Activity
In related news, CFO Tania Secor sold 6,643 shares of Integral Ad Science stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $11.24, for a total value of $74,667.32. Following the completion of the transaction, the chief financial officer now directly owns 251,366 shares in the company, valued at approximately $2,825,353.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Integral Ad Science news, CFO Tania Secor sold 6,643 shares of Integral Ad Science stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $11.24, for a total value of $74,667.32. Following the completion of the transaction, the chief financial officer now directly owns 251,366 shares in the company, valued at $2,825,353.84. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Lisa Utzschneider sold 10,481 shares of the business’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the transaction, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,006 shares of company stock worth $240,296. 2.00% of the stock is currently owned by corporate insiders.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading
- Five stocks we like better than Integral Ad Science
- What is a Dividend King?
- Intel: Is Now the Time to Be Brave?
- Industrial Products Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- ESG Stocks, What Investors Should Know
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.